Why the study?
Do hepatic native T1 and extracellular volume fraction predict adverse cardiovascular events in patients with pulmonary arterial hypertension?
Do hepatic native T1 and extracellular volume fraction predict adverse cardiovascular events in patients with pulmonary arterial hypertension?
Hepatic T1 mapping and extracellular volume fraction may serve as novel imaging biomarkers for predicting adverse cardiovascular events in patients with pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
May support hepatic T1 mapping for PAH risk stratification; leaves open incremental value and need for prospective validation.
=0.009) remained as an independent prognostic factor for the secondary end point. Conclusions Hepatic T1 mapping values were predictors of adverse cardiovascular events in participants with pulmonary arterial hypertension and could be novel imaging biomarkers for poor prognosis recognition.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: